The American journal of emergency medicine
-
Case Reports
Ultrasound-guided analgesic injection for acromioclavicular joint separation in the emergency department.
We present the first documented case of an emergency clinician treating the pain of an acute Acromioclavicular (AC) joint separation through ultrasound (US) guided injection of an anesthetic agent. A 41 year old male presented with an acute traumatic grade III AC joint separation after falling off a scooter, and his pain was not significantly improved with oral medication. ⋯ In orthopedics and physiatry literature, US guided AC joint injections have been shown to be far more efficacious than landmark guided AC joint injections, yet this is the first known case documenting injection in the Emergency Department (ED). The superficial location of the AC joint, its ease of identification by US, and the rapid onset of analgesia by intra-articular injection makes the US-guided anesthetic injection of the AC joint an ideal tool to incorporate into a multimodal approach to pain management in AC joint separations.
-
Impacted esophageal foreign bodies typically first present to the emergency department, with coins being most common in children and food boluses most common in adults. Controversy exists regarding the best treatment options in these cases. We report two cases, one pediatric and one adult, where the use of a novel substitute Hurst dilator constructed of materials regularly found in all EDs was successfully used to treat impacted esophageal foreign bodies.
-
We investigated the state of inflammation, PTX3 level and other routine inflammatory markers (high sensitivity C-reactive protein [hsCRP], and white blood cells [WBC]), in patients who presented to the emergency department (ED) with migraine. We also investigated the relationship between the clinical presentation, PTX3 level, and other routine inflammatory markers in the emergency management of these patients. ⋯ This is the first study to investigate plasma levels of PTX3 in patients with acute migraine. PTX3 as a biomarker may be used as an additional examination to the current subjective criteria to support the diagnosis of patients presenting to the ED with an acute migraine attack.